| Larry J Pugel, Ph.d., Lpc | |
|
131 E State St Albion PA 16401-1348 | |
| (814) 935-4074 | |
| (440) 536-4115 |
| Full Name | Larry J Pugel, Ph.d., Lpc |
|---|---|
| Speciality | Counselor - Professional |
| Location | 131 E State St, Albion, Pennsylvania |
| Authorized Official Name and Position | Ruth Elaine Pugel (OFFICE MANAGER) |
| Authorized Official Contact | 3035178084 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Larry J Pugel, Ph.d., Lpc 4345 N Bend Rd Ashtabula OH 44004-9797 Ph: (303) 517-8084 | Larry J Pugel, Ph.d., Lpc 131 E State St Albion PA 16401-1348 Ph: (814) 935-4074 |
| NPI Number | 1073222816 |
|---|---|
| Provider Enumeration Date | 11/21/2022 |
| Last Update Date | 11/21/2022 |
| Certification Date | 11/21/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073222816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
News Archive
The results showed that patients were far more likely to ask factual questions of all healthcare professionals, such as the length of their hospital stay, than they were to pose questions that might be perceived as challenging clinical abilities, such as whether that healthcare professional had washed his/her hands.
Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.
Though the cause of Alzheimer's disease still is unknown, recent studies have implicated three proteins strongly in its onset. New research from the University of Alabama at Birmingham, the Gladstone Institutes and the Baylor College of Medicine indicates that interactions between those three proteins might lead to brain dysfunction and AD in a mouse model of the disease.
TauRx Therapeutics Ltd, a clinical-stage biopharmaceutical company developing a novel treatment for Alzheimer's disease, has expanded its international clinical trials by adding new research centers across the U.S.
› Verified 7 days ago